NASDAQ:JAGX Jaguar Health (JAGX) Stock Price, News & Analysis → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free JAGX Stock Alerts $0.31 +0.04 (+15.74%) (As of 05:12 PM ET) Add Compare Share Share Today's Range$0.25▼$0.3250-Day Range$0.06▼$0.3252-Week Range$0.05▼$1.22Volume65.48 million shsAverage Volume53.59 million shsMarket Capitalization$85.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Jaguar Health alerts: Email Address Jaguar Health MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy5.20% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.40) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.35 out of 5 starsMedical Sector878th out of 915 stocksPharmaceutical Preparations Industry414th out of 426 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Jaguar Health.Read more about Jaguar Health's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted5.20% of the outstanding shares of Jaguar Health have been sold short.Short Interest Ratio / Days to CoverJaguar Health has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Jaguar Health has recently decreased by 27.14%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldJaguar Health does not currently pay a dividend.Dividend GrowthJaguar Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JAGX. Previous Next 2.4 News and Social Media Coverage News SentimentJaguar Health has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Jaguar Health this week, compared to 2 articles on an average week.Search Interest31 people have searched for JAGX on MarketBeat in the last 30 days. This is an increase of 158% compared to the previous 30 days.MarketBeat FollowsOnly 16 people have added Jaguar Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Jaguar Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.16% of the stock of Jaguar Health is held by insiders.Percentage Held by InstitutionsOnly 12.04% of the stock of Jaguar Health is held by institutions.Read more about Jaguar Health's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Jaguar Health are expected to grow in the coming year, from ($0.40) to ($0.07) per share.Price to Book Value per Share RatioJaguar Health has a P/B Ratio of 4.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Jaguar Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About Jaguar Health Stock (NASDAQ:JAGX)Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.Read More JAGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JAGX Stock News HeadlinesMay 8, 2024 | americanbankingnews.comJaguar Health (NASDAQ:JAGX) Research Coverage Started at StockNews.comMay 7, 2024 | investorplace.comWant $10,000? Invest $1,000 in These 3 Penny Stocks NowMay 9, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…May 6, 2024 | finance.yahoo.comCrofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in DogsApril 30, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)April 17, 2024 | msn.comWhy Jaguar Health Stock Is Up TodayApril 17, 2024 | markets.businessinsider.comGold Moves Higher; Morgan Stanley Earnings Top ViewsApril 16, 2024 | investorplace.comWhy Is Jaguar Health (JAGX) Stock Up 44% Today?May 9, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…April 10, 2024 | benzinga.comS&P 500 Down 1%; Delta Air Lines Posts Upbeat EarningsApril 10, 2024 | msn.comJaguar Health shareholders approve reverse stock splitApril 10, 2024 | investorplace.comWhat Is Going on With Jaguar Health (JAGX) Stock Today?April 10, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of StockholdersApril 9, 2024 | msn.comWhy Jaguar Health Stock Is Soaring After-HoursApril 3, 2024 | finance.yahoo.comJaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)April 2, 2024 | finance.yahoo.comJaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | investorplace.comJAGX Stock Earnings: Jaguar Health Misses Revenue for Q4 2023April 1, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Reports 2023 Financial ResultsMarch 31, 2024 | markets.businessinsider.comWhat Wall Street expects from Jaguar Health's earningsMarch 20, 2024 | edition.cnn.comJaguar Health, Inc.March 20, 2024 | finance.yahoo.comGEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to MarketMarch 15, 2024 | finance.yahoo.comCapricor Therapeutics, Inc. (4LN2.F)March 1, 2024 | msn.comWhat In The World Is Going On With Jaguar Health (JAGX) Stock?February 23, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Requests and Receives Hearing on Nasdaq Listing ComplianceFebruary 17, 2024 | money.usnews.comJaguar Health IncFebruary 15, 2024 | finance.yahoo.comJaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in DogsFebruary 14, 2024 | finanznachrichten.deJaguar Health, Inc.: Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct ReliefSee More Headlines Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/17/2021Today5/09/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:JAGX CUSIPN/A CIK1585608 Webwww.jaguaranimalhealth.com Phone(415) 371-8300FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,300,000.00 Net Margins-423.11% Pretax Margin-429.27% Return on Equity-837.11% Return on Assets-80.76% Debt Debt-to-Equity Ratio6.33 Current Ratio2.00 Quick Ratio1.34 Sales & Book Value Annual Sales$9.76 million Price / Sales8.22 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book4.15Miscellaneous Outstanding Shares276,216,000Free Float276,161,000Market Cap$80.21 million OptionableNo Data Beta0.89 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMs. Lisa A. Conte (Age 65)Founder, CEO, President & Director Comp: $771.4kDr. Pravin R. Chaturvedi Ph.D. (Age 61)Chief Scientific Officer & Chair of Scientific Advisory Board Comp: $539.04kMr. Jonathan S. Wolin CPA (Age 61)J.D., M.B.A., Chief of Staff, Chief Compliance Officer & General Counsel Comp: $520.29kMr. Ian H. Wendt M.B.A. (Age 56)Chief Commercial Officer Comp: $441.31kDr. Steven R. King Ph.D. (Age 66)Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary Comp: $477.66kMs. Carol R. Lizak M.B.A. (Age 60)Chief Financial Officer Mr. Peter HodgeSenior Director of Investor Relations, Business Development & Special EventsDr. Karen J. Brunke Ph.D. (Age 71)Executive VP of Corporate & Business Development Mr. David SesinChief Manufacturing OfficerDr. Massimo Radaelli M.B.A. (Age 66)Ph.D., President of Jaguar International More ExecutivesKey CompetitorsCorvus PharmaceuticalsNASDAQ:CRVSHookipa PharmaNASDAQ:HOOKConnect BiopharmaNASDAQ:CNTBLifeVantageNASDAQ:LFVNTempest TherapeuticsNASDAQ:TPSTView All Competitors JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed in 2024? Jaguar Health's stock was trading at $0.1514 at the start of the year. Since then, JAGX shares have increased by 107.6% and is now trading at $0.3143. View the best growth stocks for 2024 here. Are investors shorting Jaguar Health? Jaguar Health saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 14,360,000 shares, a decline of 27.1% from the March 31st total of 19,710,000 shares. Based on an average trading volume of 59,870,000 shares, the days-to-cover ratio is currently 0.2 days. View Jaguar Health's Short Interest. When is Jaguar Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our JAGX earnings forecast. How were Jaguar Health's earnings last quarter? Jaguar Health, Inc. (NASDAQ:JAGX) released its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.09. The biotechnology company earned $0.63 million during the quarter. Jaguar Health had a negative net margin of 423.11% and a negative trailing twelve-month return on equity of 837.11%. During the same quarter last year, the company posted ($0.63) earnings per share. When did Jaguar Health's stock split? Shares of Jaguar Health reverse split on the morning of Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. What other stocks do shareholders of Jaguar Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT). When did Jaguar Health IPO? Jaguar Health (JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:JAGX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.